ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Alector Inc

Alector Inc (ALEC)

5.3681
-0.0719
( -1.32% )
Updated: 11:21:04

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
5.3681
Bid
5.35
Ask
5.37
Volume
115,779
5.31 Day's Range 5.60
3.66 52 Week Range 9.065
Market Cap
Previous Close
5.44
Open
5.48
Last Trade
8
@
5.3682
Last Trade Time
11:22:40
Financial Volume
$ 630,544
VWAP
5.4461
Average Volume (3m)
595,957
Shares Outstanding
95,749,259
Dividend Yield
-
PE Ratio
-3.93
Earnings Per Share (EPS)
-1.36
Revenue
97.06M
Net Profit
-130.39M

About Alector Inc

Alector Inc is a clinical stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies which are designed to simultaneously counteract pathologies by restoring healthy immune function to... Alector Inc is a clinical stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies which are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline product inlcude AL001, AL002, AL003, and AL101. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
Headquarters
Wilmington, Delaware, USA
Founded
1970
Alector Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker ALEC. The last closing price for Alector was $5.44. Over the last year, Alector shares have traded in a share price range of $ 3.66 to $ 9.065.

Alector currently has 95,749,259 shares outstanding. The market capitalization of Alector is $512.26 million. Alector has a price to earnings ratio (PE ratio) of -3.93.

ALEC Latest News

Alector to Participate in Upcoming Healthcare Conferences

SOUTH SAN FRANCISCO, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, today announced that management...

Alector Reports First Quarter 2024 Financial Results and Provides Business Update

Data from INVOKE-2, evaluating the most advanced TREM2 candidate in clinical development for early Alzheimer’s disease, on track for Q4 2024 Strengthened leadership team with key appointments:...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.09811.86148007595.275.725.254663935.46891233CS
40.25815.050880626225.115.724.84421365.28730751CS
12-0.8619-13.8346709476.237.57734.85959575.98466153CS
261.058124.54988399074.318.94.286454926.32621063CS
52-2.2119-29.18073878637.589.0653.666376666.32068714CS
156-12.0619-69.201950659817.4343.323.6669347514.50042786CS
260-14.5519-73.051706827319.92453.6664237716.09232295CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MMVMultiMetaVerse Holdings Ltd
$ 1.8301
(209.77%)
86.71M
GTBPGT Biopharma Inc
$ 9.028
(189.36%)
37.48M
BRSHBruush Oral Care Inc
$ 0.2436
(107.85%)
68.57M
TANHTantech Holdings Ltd
$ 1.215
(84.93%)
48.6M
CNEYCN Energy Group Inc
$ 1.0399
(56.38%)
10.81M
MTCMMTec Inc
$ 2.5899
(-63.05%)
6.81M
AKTSAkoustis Technologies Inc
$ 0.185
(-48.06%)
9.53M
VIRIVirios Therapeutics Inc
$ 0.1826
(-48.04%)
2.46M
FLJFLJ Group Limited
$ 0.842471
(-45.65%)
3.38M
JAGXJaguar Health Inc
$ 0.1457
(-43.64%)
32.6M
CRKNCrown Electrokinetics Corporation
$ 0.181
(5.85%)
468.68M
FFIEFaraday Future Intelligent Electric Inc
$ 1.4709
(42.81%)
393.04M
GWAVGreenwave Technology Solutions Inc
$ 0.141
(-8.50%)
233.22M
MMVMultiMetaVerse Holdings Ltd
$ 1.8301
(209.77%)
86.71M
SINTSiNtx Technologies Inc
$ 0.1144
(34.59%)
73.33M

Your Recent History

Delayed Upgrade Clock